5 Key Takeaways

• 1

  Noninfectious conjunctival hyperemia is a growing global issue, driven by lifestyle factors like digital eye strain and pollution.

• 2

  Dry eye disease and ocular allergy are leading causes of chronic redness, affecting significant portions of the population.

• 3

  Current management often relies on over-the-counter drops, but traditional decongestants have limitations like tachyphylaxis.

• 4

  Low-dose brimonidine 0.025% shows promise for redness reduction without tachyphylaxis, but long-term data is needed.

• 5

  There is a critical need for dedicated management guidelines and better patient education to address conjunctival hyperemia.